Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review

Background: The management and treatment of major depressive disorder are major public health challenges, the lifetime prevalence of this illness being 4.4%–20% in the general population. Major depressive disorder and treatment resistant depression appear to be, in part, related to a dysfunction of...

Full description

Bibliographic Details
Main Authors: Antoine Yrondi, Marie Sporer, Patrice Péran, Laurent Schmitt, Christophe Arbus, Anne Sauvaget
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:Brain Stimulation
Subjects:
ECT
Online Access:http://www.sciencedirect.com/science/article/pii/S1935861X17309464
id doaj-0bb618677f66462c8103fd78db62bcf7
record_format Article
spelling doaj-0bb618677f66462c8103fd78db62bcf72021-03-19T07:11:20ZengElsevierBrain Stimulation1935-861X2018-01-011112951Electroconvulsive therapy, depression, the immune system and inflammation: A systematic reviewAntoine Yrondi0Marie Sporer1Patrice Péran2Laurent Schmitt3Christophe Arbus4Anne Sauvaget5Psychiatric Department, CHU Toulouse-Purpan, 330 Avenue de Grande Bretagne, 31059 Toulouse, France; Toulouse NeuroImaging Center, ToNIC, University of Toulouse, Inserm, UPS, France; Corresponding author. Service de psychiatrie et psychologie médicale, CHU Toulouse-Purpan, 330 avenue de Grande Bretagne, 31059 Toulouse, France.Psychiatric Department, CHU Toulouse-Purpan, 330 Avenue de Grande Bretagne, 31059 Toulouse, FranceToulouse NeuroImaging Center, ToNIC, University of Toulouse, Inserm, UPS, FrancePsychiatric Department, CHU Toulouse-Purpan, 330 Avenue de Grande Bretagne, 31059 Toulouse, FrancePsychiatric Department, CHU Toulouse-Purpan, 330 Avenue de Grande Bretagne, 31059 Toulouse, France; Toulouse NeuroImaging Center, ToNIC, University of Toulouse, Inserm, UPS, FranceCHU Nantes, Addictology and Liaison Psychiatry Department, Neuromodulation Unit in Psychiatry, Nantes, FranceBackground: The management and treatment of major depressive disorder are major public health challenges, the lifetime prevalence of this illness being 4.4%–20% in the general population. Major depressive disorder and treatment resistant depression appear to be, in part, related to a dysfunction of the immune response. Among the treatments for depression ECT occupies an important place. The underlying cerebral mechanisms of ECT remain unclear. Objectives/Hypothesis: The aim of this review is to survey the potential actions of ECT on the immuno-inflammatory cascade activated during depression. Methods: A systematic search of the literature was carried out, using the bibliographic search engines PubMed and Embase. The search covered articles published up until october 2017.The following MESH terms were used: Electroconvulsive therapy AND (inflammation OR immune OR immunology). Results: Our review shows that there is an acute immuno-inflammatory response immediately following an ECT session. There is an acute stress reaction. Studies show an increase in the plasma levels of cortisol and of interleukins 1 and 6. However, at the end of the course of treatment, ECT produces, in the long term, a fall in the plasma level of cortisol, a reduction in the levels of TNF alpha and interleukin 6. Limitations: One of the limitations of this review is that a large number of studies are relatively old, with small sample sizes and methodological bias. Conclusion: Advances in knowledge of the immuno-inflammatory component of depression seem to be paving the way towards models to explain the mechanism of action of ECT.http://www.sciencedirect.com/science/article/pii/S1935861X17309464Depressive disorderInflammationECTImmuneCortisol
collection DOAJ
language English
format Article
sources DOAJ
author Antoine Yrondi
Marie Sporer
Patrice Péran
Laurent Schmitt
Christophe Arbus
Anne Sauvaget
spellingShingle Antoine Yrondi
Marie Sporer
Patrice Péran
Laurent Schmitt
Christophe Arbus
Anne Sauvaget
Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review
Brain Stimulation
Depressive disorder
Inflammation
ECT
Immune
Cortisol
author_facet Antoine Yrondi
Marie Sporer
Patrice Péran
Laurent Schmitt
Christophe Arbus
Anne Sauvaget
author_sort Antoine Yrondi
title Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review
title_short Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review
title_full Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review
title_fullStr Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review
title_full_unstemmed Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review
title_sort electroconvulsive therapy, depression, the immune system and inflammation: a systematic review
publisher Elsevier
series Brain Stimulation
issn 1935-861X
publishDate 2018-01-01
description Background: The management and treatment of major depressive disorder are major public health challenges, the lifetime prevalence of this illness being 4.4%–20% in the general population. Major depressive disorder and treatment resistant depression appear to be, in part, related to a dysfunction of the immune response. Among the treatments for depression ECT occupies an important place. The underlying cerebral mechanisms of ECT remain unclear. Objectives/Hypothesis: The aim of this review is to survey the potential actions of ECT on the immuno-inflammatory cascade activated during depression. Methods: A systematic search of the literature was carried out, using the bibliographic search engines PubMed and Embase. The search covered articles published up until october 2017.The following MESH terms were used: Electroconvulsive therapy AND (inflammation OR immune OR immunology). Results: Our review shows that there is an acute immuno-inflammatory response immediately following an ECT session. There is an acute stress reaction. Studies show an increase in the plasma levels of cortisol and of interleukins 1 and 6. However, at the end of the course of treatment, ECT produces, in the long term, a fall in the plasma level of cortisol, a reduction in the levels of TNF alpha and interleukin 6. Limitations: One of the limitations of this review is that a large number of studies are relatively old, with small sample sizes and methodological bias. Conclusion: Advances in knowledge of the immuno-inflammatory component of depression seem to be paving the way towards models to explain the mechanism of action of ECT.
topic Depressive disorder
Inflammation
ECT
Immune
Cortisol
url http://www.sciencedirect.com/science/article/pii/S1935861X17309464
work_keys_str_mv AT antoineyrondi electroconvulsivetherapydepressiontheimmunesystemandinflammationasystematicreview
AT mariesporer electroconvulsivetherapydepressiontheimmunesystemandinflammationasystematicreview
AT patriceperan electroconvulsivetherapydepressiontheimmunesystemandinflammationasystematicreview
AT laurentschmitt electroconvulsivetherapydepressiontheimmunesystemandinflammationasystematicreview
AT christophearbus electroconvulsivetherapydepressiontheimmunesystemandinflammationasystematicreview
AT annesauvaget electroconvulsivetherapydepressiontheimmunesystemandinflammationasystematicreview
_version_ 1724214143448252416